ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Combination of smoking and Epstein-Barr virus DNA is a predictor of poor prognosis for nasopharyngeal carcinoma: a long-term follow-up retrospective study

Li, Wanxia; Yang, Chao; Zhao, Feipeng; Li, Junzheng; Li, Zonghua; Ouyang, Ping; Yuan, Xiaofei; Wu, Shuting; Yuan, Yue; Cui, Linchong; Feng, Huiru; Lin, Danfan; Chen, Zilu; Lu, Juan*; Peng, Xiaohong*; Chen, Jing*南方医科大学
BMC CANCER2022-12-5DOI: 10.1186/s12885-022-10297-w
2被引6阅读
引用收藏
分享

摘要

Background: This retrospective study was performed to determine the prognostic potential of smoking and its combination with pre-treatment plasma Epstein-Barr virus (EBV) DNA levels in patients with nasopharyngeal carcinoma (NPC). Methods: Medical records of 1080 non-metastatic NPC patients who received intensity-modulated radiotherapy were reviewed. Male patients were categorized as never and ever smokers, and the smoking amount, duration, and cumulative consumption were used to evaluate dose-dependent effects. Survival outcomes were assessed using Kaplan-Meier survival analysis and the multivariate Cox regression analysis. Propensity score matching (PSM) was constructed. Results: The 5-year overall survival (OS) was worse for ever smokers than never smokers, and significantly decreased with the increase of smoking amount, duration, and cumulative consumption. Compared with never smokers, the multivariate-adjusted hazard ratio (HR) of death was higher in ever smokers (HR = 1.361, P = 0.049), those smoked >= 20 cigarettes/day (HR = 1.473, P = 0.017), those smoked for >= 30 years (HR = 1.523, P = 0.023), and those cumulative smoked for >= 30 pack-years (HR = 1.649, P = 0.005). The poor prognostic effects of smoking was also confirmed in the PSM analysis. The combination of cumulative smoking consumption and pre-treatment EBV DNA levels was proven to be an independent poor prognostic factor for male NPC, and the risk of death, progression, and distant metastases gradually increased with both factors (P < 0.001). Conclusions: Combination of smoking and pre-treatment EBV DNA levels as a predictor of poor prognosis could further improve the risk stratification and prognostication for NPC.

学科与关键词

关键词
SmokingEBV DNAPrognosisCombinationNasopharyngeal carcinoma
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
BMC CANCER
发表日期
2022-12-05
卷期
第 22 卷, 第 1 期
页码
1262
DOI
10.1186/s12885-022-10297-w
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China; Natural Science Foundation of Guangdong Province [81602570]; Guangdong Medical Science and Technology Research Found [2020A1515010596, 2019A1515010968]; Guangzhou Science and Technology Program Project [A2020078]; [202102010041]

作者

  • L

    Li, Wanxia (第一作者)

    southern med univ

  • Y

    Yang, Chao

    southern med univ

查看全部 16 位作者收起作者
  • Z

    Zhao, Feipeng

    chengdu second peoples hosp

  • L

    Li, Junzheng

    southern med univ

  • L

    Li, Zonghua

  • O

    Ouyang, Ping

    southern med univ

  • Y

    Yuan, Xiaofei

    southern med univ

  • W

    Wu, Shuting

    southern med univ

  • Y

    Yuan, Yue

    southern med univ

  • C

    Cui, Linchong

    southern med univ

  • F

    Feng, Huiru

    southern med univ

  • L

    Lin, Danfan

    southern med univ

  • C

    Chen, Zilu

    southern med univ

  • L

    Lu, Juan (通讯)

    southern med univ

  • P

    Peng, Xiaohong (通讯)

    southern med univ

  • C

    Chen, Jing (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417